Press Releases Year None20202019201820172016 Jul 30, 2020 Imara Announces IMR-687 Granted Fast Track Designation and Rare Pediatric Disease Designation for Treatment of Beta-Thalassemia Jun 29, 2020 Imara Added to Membership of U.S. Small-Cap Russell 2000® Index Jun 25, 2020 Imara Announces Recipients of Real Impact Grants Program to Support People Affected by Rare Genetic Blood Disorders Jun 24, 2020 Imara Receives Orphan Drug Designation for IMR-687 for Treatment of Beta-thalassemia Jun 12, 2020 Imara Presents Positive Interim Results from Phase 2a Study of IMR-687 in Sickle Cell Disease at the Virtual European Hematology Association Annual Congress May 21, 2020 Imara to Present Data on IMR-687 in Sickle Cell Disease at the 25th Annual European Hematology Association (EHA) Congress May 07, 2020 Imara Reports First Quarter 2020 Financial Results and Business Highlights May 06, 2020 Imara Launches ‘Real Impact’ Community Support Program to Address Unmet Needs Affecting People with Rare Genetic Blood Disorders May 04, 2020 Imara Announces Appointment of Stephen M. Migausky as General Counsel Apr 23, 2020 Imara Strengthens Board of Directors With Appointment of Edward R. Conner, M.D. Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 12
Press Releases Year None20202019201820172016 Jul 30, 2020 Imara Announces IMR-687 Granted Fast Track Designation and Rare Pediatric Disease Designation for Treatment of Beta-Thalassemia Jun 29, 2020 Imara Added to Membership of U.S. Small-Cap Russell 2000® Index Jun 25, 2020 Imara Announces Recipients of Real Impact Grants Program to Support People Affected by Rare Genetic Blood Disorders Jun 24, 2020 Imara Receives Orphan Drug Designation for IMR-687 for Treatment of Beta-thalassemia Jun 12, 2020 Imara Presents Positive Interim Results from Phase 2a Study of IMR-687 in Sickle Cell Disease at the Virtual European Hematology Association Annual Congress May 21, 2020 Imara to Present Data on IMR-687 in Sickle Cell Disease at the 25th Annual European Hematology Association (EHA) Congress May 07, 2020 Imara Reports First Quarter 2020 Financial Results and Business Highlights May 06, 2020 Imara Launches ‘Real Impact’ Community Support Program to Address Unmet Needs Affecting People with Rare Genetic Blood Disorders May 04, 2020 Imara Announces Appointment of Stephen M. Migausky as General Counsel Apr 23, 2020 Imara Strengthens Board of Directors With Appointment of Edward R. Conner, M.D. Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 12
Jul 30, 2020 Imara Announces IMR-687 Granted Fast Track Designation and Rare Pediatric Disease Designation for Treatment of Beta-Thalassemia
Jun 25, 2020 Imara Announces Recipients of Real Impact Grants Program to Support People Affected by Rare Genetic Blood Disorders
Jun 12, 2020 Imara Presents Positive Interim Results from Phase 2a Study of IMR-687 in Sickle Cell Disease at the Virtual European Hematology Association Annual Congress
May 21, 2020 Imara to Present Data on IMR-687 in Sickle Cell Disease at the 25th Annual European Hematology Association (EHA) Congress
May 06, 2020 Imara Launches ‘Real Impact’ Community Support Program to Address Unmet Needs Affecting People with Rare Genetic Blood Disorders
